MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease

Brain

Volumn 139, Issue 3, 2016, Pages 908-921

  Zhu, Qiong Bin ^a   Unmehopa, Unga ^b   Bossers, Koen ^b   Hu, Yu Ting ^a   Verwer, Ronald ^b   Balesar, Rawien ^b   Zhao, Juan ^b   Bao, Ai Min ^a   Swaab, Dick ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Alzheimer's disease; Early growth response 1; microRNA 132; Nucleus basalis of Meynert

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; APOLIPOPROTEIN E; CHOLINE ACETYLTRANSFERASE; EARLY GROWTH RESPONSE FACTOR 1; MICRORNA 132; TAU PROTEIN; EGR1 PROTEIN, HUMAN; MICRORNA; MIRN132 MICRORNA, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN NERVE CELL; CELL DENSITY; CELL SIZE; CEREBROSPINAL FLUID PH; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; MEYNERT BASAL NUCLEUS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPIL THREAD; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RATING SCALE; SILVER STAINING; SYNAPTIC TRANSMISSION; TIME OF DEATH; TISSUE FIXATION; TISSUE PRESERVATION; VERY ELDERLY; BIOSYNTHESIS; DISEASE COURSE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; SINGLE BLIND PROCEDURE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASAL NUCLEUS OF MEYNERT; DISEASE PROGRESSION; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEURONS; SINGLE-BLIND METHOD;

EID: 84964687584     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv383     Document Type: Article

References (55)

1. Allen SJ, MacGowan SH, Tyler S, Wilcock GK, Robertson AG, Holden PH, et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett 1997;239:33-6.
2. Arendt T, Bigl V, Tennstedt A, Arendt A. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 1985;14:1-14.
3. Baker-Nigh A, Vahedi S, Davis EG, Weintraub S, Bigio EH, Klein WL, et al. Neuronal amyloid-beta accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Brain 2015;138:1722-37.
4. Ben Aziz-Aloya R, Seidman S, Timberg R, Sternfeld M, Zakut H, Soreq H. Expression of a human acetylcholinesterase promoterreporter construct in developing neuromuscular junctions of Xenopus embryos. Proc Natl Acad Sci USA 1993;90:2471-5.
5. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004;101:2173-8.
6. Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, et al. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain 2010;133:3699-723.
7. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 1994;87:554-67.
8. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
9. Conover WJ. Practical nonparametric statistics. 2nd edn. New York: Wiley; 1980.
10. Cullen KM, Halliday GM, Double KL, Brooks WS, Creasey H, Broe GA. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease. Neuroscience 1997;78:641-52.
11. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-55.
12. Dubelaar EJ, Mufson EJ, ter Meulen WG, Van Heerikhuize JJ, Verwer RW, Swaab DF. Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 2006;65:257-66.
13. Dubelaar EJ, Verwer RW, Hofman MA, Van Heerikhuize JJ, Ravid R, Swaab DE. ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 2004;63:159-69.
14. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010;65:373-84.
15. Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. Brain Res 1993;601:164-72.
16. Etienne P, Robitaille Y, Wood P, Gauthier S, Nair NP, Quirion R. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience 1986;19:1279-91.
17. Fiore R, Siegel G, Schratt G. MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta 2008;1779:471-8.
18. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8.
19. Gao SF, Qi XR, Zhao J, Balesar R, Bao AM, Swaab DF. Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb Cortex 2013;23:2956-64.
20. Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 1999;411:693-704.
21. Gomez Ravetti M, Rosso OA, Berretta R, Moscato P. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 2010;5:e10153.
22. Grothe MJ, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J Neurol 2014;261:1939-48.
23. Hebert SS, Sergeant N, Buee L. MicroRNAs and the regulation of Tau metabolism. Int J Alzheimers Dis 2012;2012:406561.
24. Kandane-Rathnayake RK, Enticott JC, Phillips LE. Data distribution: normal or abnormal? What to do about it. Transfusion 2013;53:701-2.
25. Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 2004;29:427-41.
26. Killick R, Ribe EM, Al-Shawi R, Malik B, Hooper C, Fernandes C, et al. Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol Psychiatry 2014;19:88-98.
27. Kim MJ, Lee KM, Son YD, Jeon HA, Kim YB, Cho ZH. Increased basal forebrain metabolism in mild cognitive impairment: an evidence for brain reserve in incipient dementia. J Alzheimers Dis 2012;32:927-38.
28. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 2007;8:499-509.
29. Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, et al. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med 2013;5:1613-34.
30. Lu Y, Li T, Qureshi HY, Han D, Paudel HK. Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain. J Biol Chem 2011;286:20569-81.
31. MacGibbon GA, Lawlor PA, Walton M, Sirimanne E, Faull RL, Synek B, et al. Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol 1997;147:316-32.
32. Mesulam M, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 2004;55:815-28.
33. Mesulam MM. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease. J Comp Neurol 2013;521:4124-44.
34. Mesulam MM, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983;214:170-97.
35. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 2010;67:953-66.
36. Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci Lett 1983;36:195-9.
37. Pappas BA, Bayley PJ, Bui BK, Hansen LA, Thal LJ. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol Aging 2000;21:11-7.
38. Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-9.
39. Renbaum P, Beeri R, Gabai E, Amiel M, Gal M, Ehrengruber MU, et al. Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells. Gene 2003;318:113-24.
40. Rensink AA, Gellekink H, Otte-Holler I, ten Donkelaar HJ, de Waal RM, Verbeek MM, et al. Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease. Acta Neuropathol 2002;104:525-33.
41. Rinne JO, Paljarvi L, Rinne UK. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol Sci 1987;79:67-76.
42. Salehi A, Lucassen PJ, Pool CW, Gonatas NK, Ravid R, Swaab DF. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 1994;59:871-80.
43. Sassin I, Schultz C, Thal DR, Rub U, Arai K, Braak E, et al. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 2000;100:259-69.
44. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 2006;113:1625-44.
45. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009;31:965-73.
46. Shaltiel G, Hanan M, Wolf Y, Barbash S, Kovalev E, Shoham S, et al. Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct 2013;218:59-72.
47. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985;342:37-44.
48. Swirnoff AH, Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 1995;15:2275-87.
49. Teipel SJ, Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF, et al. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Hum Brain Mapp 2011;32:1349-62.
50. van de Nes JA, Kamphorst W, Ravid R, Swaab DF. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol 1998;96:129-38.
51. Van der Loos CM. Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem 2008;56:313-28.
52. Vana L, Kanaan NM, Ugwu IC, Wuu J, Mufson EJ, Binder LI. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol 2011;179:2533-50.
53. Venables WN, Ripley, B. D. Modern applied statistics with S. New York: Springer; 2002.
54. Veyrac A, Besnard A, Caboche J, Davis S, Laroche S. The transcription factor Zif268/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci 2014;122:89-129.
55. Vogels OJ, Broere CA, ter Laak HJ, ten Donkelaar HJ, Nieuwenhuys R, Schulte BP. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging 1990;11:3-13.